Ceramides (Cer) constitute a class of lipids present in the cell membranes where they act as structural components, but they can also work as signaling molecules. Increasing genetic and biochemical evidence supports a link between deregulation of ceramide metabolism in the brain and neurodegeneration. Here, we provide an overview of the genes and cellular pathways that link Cer with Parkinson’s disease and discuss how ceramide pathobiology is gaining increasing interest in the understanding of the pathological mechanisms that contribute to the disease and in the clinical and therapeutic side
Sphingolipid metabolism starts with the biosynthesis of ceramide, a bioactive lipid and the backbone...
Age-associated neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson's d...
Alzheimer's disease (AD), the most common chronic and progressive neurodegenerative disorder, is cha...
Ceramides (Cer) constitute a class of lipids present in the cell membranes where they act as structu...
Ceramide is a bioactive sphingolipid involved in numerous cellular processes. In addition to being t...
Background: Mutations in the gene coding for glucocerebrosidase (GBA), which metabolizes glucosylcer...
Mutations in the gene coding for glucocerebrosidase (GBA), which metabolizes glucosylceramide (a mon...
Ceramide, the precursor of all complex sphingolipids, is a potent signaling molecule that mediates k...
Neurodegenerative diseases represent a class of fatal brain disorders for which the number of effect...
Sphingolipids exhibit extreme functional and chemical diversity that is in part determined by their ...
Objective: Alterations of sphingolipid metabolism are implicated in the pathogenesis of many neurode...
frontotemporal lobar dementia (FTLD) are characterized by progressive neuronal loss but differ in th...
AbstractSimple sphingolipids such as ceramide and sphingomyelin (SM) as well as more complex glycosp...
Sphingolipids constitute a complex class of bioactive lipids with diverse structural and functional ...
Mutations in glucocerebrosidase (GBA) are the most prevalent genetic risk factor for Lewy body disor...
Sphingolipid metabolism starts with the biosynthesis of ceramide, a bioactive lipid and the backbone...
Age-associated neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson's d...
Alzheimer's disease (AD), the most common chronic and progressive neurodegenerative disorder, is cha...
Ceramides (Cer) constitute a class of lipids present in the cell membranes where they act as structu...
Ceramide is a bioactive sphingolipid involved in numerous cellular processes. In addition to being t...
Background: Mutations in the gene coding for glucocerebrosidase (GBA), which metabolizes glucosylcer...
Mutations in the gene coding for glucocerebrosidase (GBA), which metabolizes glucosylceramide (a mon...
Ceramide, the precursor of all complex sphingolipids, is a potent signaling molecule that mediates k...
Neurodegenerative diseases represent a class of fatal brain disorders for which the number of effect...
Sphingolipids exhibit extreme functional and chemical diversity that is in part determined by their ...
Objective: Alterations of sphingolipid metabolism are implicated in the pathogenesis of many neurode...
frontotemporal lobar dementia (FTLD) are characterized by progressive neuronal loss but differ in th...
AbstractSimple sphingolipids such as ceramide and sphingomyelin (SM) as well as more complex glycosp...
Sphingolipids constitute a complex class of bioactive lipids with diverse structural and functional ...
Mutations in glucocerebrosidase (GBA) are the most prevalent genetic risk factor for Lewy body disor...
Sphingolipid metabolism starts with the biosynthesis of ceramide, a bioactive lipid and the backbone...
Age-associated neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson's d...
Alzheimer's disease (AD), the most common chronic and progressive neurodegenerative disorder, is cha...